Inactivation of human viruses by povidone-iodine in comparison with other antiseptics

被引:135
作者
Kawana, R
Kitamura, T
Nakagomi, O
Matsumoto, I
Arita, M
Yoshihara, N
Yanagi, K
Yamada, A
Morita, O
Yoshida, Y
Furuya, Y
Chiba, S
机构
[1] IWATE MED UNIV,MORIOKA,IWATE,JAPAN
[2] TOYAMA INST HLTH,TOYAMA,JAPAN
[3] NATL INST INFECT DIS,TOKYO,JAPAN
[4] AKITA UNIV,SCH MED,AKITA 010,JAPAN
[5] HOYO HOSP,ISHIDORIYA,IWATE,JAPAN
[6] KANAGAWA PREFECTURAL PUBL HLTH LAB,YOKOHAMA,KANAGAWA,JAPAN
[7] SAPPORO MED COLL,SAPPORO,HOKKAIDO 060,JAPAN
关键词
virucidal activities; povidone-iodine; chlorhexidine gluconate; alkyldiaminoethylglycine hydrochloride; benzalkonium chloride; benzethonium chloride;
D O I
10.1159/000246027
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Inactivation of a range of viruses, such as adeno-, mumps, rota-, polio-(types 1 and 3), coxsackie-, rhino-, herpes simplex, rubella, measles, influenza and human immunodeficiency viruses, by povidone-iodine (PVP-I) and other commercially available antiseptics in Japan was studied in accordance with the standardized protocol in vitro. In these experiments, antiseptics such as PVP-I solution, PVP-I gargle, PVP-I cream, chlorhexidine gluconate, alkyldiaminoethyl-glycine hydrochloride, benzalkonium chloride (BAG) and benzethonium chloride (BEG) were used. PVP-I was effective against all the virus species tested. PVP-I drug products, which were examined in these experiments, inactivated all the viruses within a short period of time. Rubella, measles, mumps viruses and HN were sensitive to all of the antiseptics, and rotavirus was inactivated by BAC and BEG, while adeno-, polio-and rhinoviruses did not respond to the other antiseptics. PVP-I had a wider virucidal spectrum, covering both enveloped and nonenveloped viruses, than the other commercially available antiseptics.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 5 条
[1]  
ITAGAKI A, 1988, INT C S SER, V129, P110
[2]   THE EFFECTS OF FREQUENT NONOXYNOL-9 USE ON THE VAGINAL AND CERVICAL MUCOSA [J].
NIRUTHISARD, S ;
RODDY, RE ;
CHUTIVONGSE, S .
SEXUALLY TRANSMITTED DISEASES, 1991, 18 (03) :176-179
[3]  
OSHLACK B, 1988, INT C S SER
[4]  
SAKAKURA K, 1993, POSTGRAD MED J, V69, pS49
[5]  
*WHO INT WORK GROU, 1996, AIDS, V10, P1